- Clinica Vidabemvinda
- Brazil
We and selected partners, use cookies or similar technologies as specified in the cookie policy and privacy policy.
You can consent to the use of such technologies by closing this notice.
Customise your preferences for any tracking technology
The following allows you to customize your consent preferences for any tracking technology used to help us achieve the features and activities described below. To learn more about how these trackers help us and how they work, refer to the cookie policy. You may review and change your preferences at any time.
These trackers are used for activities that are strictly necessary to operate or deliver the service you requested from us and, therefore, do not require you to consent.
These trackers help us to deliver personalized marketing content and to operate, serve and track ads.
These trackers help us to deliver personalized marketing content to you based on your behaviour and to operate, serve and track social advertising.
These trackers help us to measure traffic and analyze your behaviour with the goal of improving our service.
These trackers help us to provide a personalized user experience by improving the quality of your preference management options, and by enabling the interaction with external networks and platforms.
Recent Comments
I read with great interest the systematic review of Gao & Jiang [1] on the use of intrauterine hCG injection prior to embryo transfer in order to increase in vitro fertilization pregnancy rates. We were very excited about the possibility of resuming the use of this strategy, which until then was out of date due to previous systematic reviews showing inconsistent and conflicting result [2, 3].
I considered the Gao & Jiang study particularly interesting because it did the analysis of subgroups according to the dose of hCG used and the type of transfer, fresh or frozen, which is of great clinical relevance.
Regarding the time of intrauterine hCG application, the authors conclude that <15 minutes before transfer results in higher pregnancy rate than 6 hours and ≥48 hours. On this point, I have an issue.
Considering that:
• The mechanism of action of hCG described by authors cited in the review would be to alter the expression of cytokines related to implantation, as well as to lead to extracellular matrix rupture and loss of tight-junction [4, 5];
• embryo implantation occurs approximately on the seventh day after fertilization;
I think that as important as the time interval between intrauterine hCG injection and the embryo transfer is the stage of the embryo at transfer, if cleavage or blastocyst, since this will determine the time interval between the two major biologic events: hCG injection signaling and embryo implantation.
From this, I would like to know if subgroup analysis could contemplate this variable (embryo stage at transfer)?
Oscar Duarte-Filho, M.D.
References
[1] Gao M, Jiang X, Li B, Li L, Duan M, Zhang X, et al.: Intrauterine injection of human chorionic gonadotropin before embryo transfer can improve in vitro fertilization-embryo transfer outcomes: a meta-analysis of randomized controlled trials. Fertil Steril2019;112(1): 89-97.e81.
[2] Ye H, Hu J, He W, Zhang Y, Li C: The efficacy of intrauterine injection of human chorionic gonadotropin before embryo transfer in assisted reproductive cycles: Meta-analysis. J Int Med Res2015;43(6): 738-746.
[3] Osman A, Pundir J, Elsherbini M, Dave S, El-Toukhy T, Khalaf Y: The effect of intrauterine HCG injection on IVF outcome: a systematic review and meta-analysis. Reprod Biomed Online2016;33(3): 350-359.
[4] Tapia-Pizarro A, Argandoña F, Palomino WA, Devoto L: Human chorionic gonadotropin (hCG) modulation of TIMP1 secretion by human endometrial stromal cells facilitates extravillous trophoblast invasion in vitro. Hum Reprod2013;28(8): 2215-2227.
[5] Sacchi S, Sena P, Degli Esposti C, Lui J, La Marca A: Evidence for expression and functionality of FSH and LH/hCG receptors in human endometrium. J Assist Reprod Genet2018;35(9): 1703-1712.
I read with great interest the systematic review of Gao & Jiang [1] on the use of intrauterine hCG injection prior to embryo transfer in order to increase in vitro fertilization pregnancy rates. We were very excited about the possibility of resuming the use of this strategy, which until then was out of date due to previous systematic reviews showing inconsistent and conflicting result [2, 3].
I considered the Gao & Jiang study particularly interesting because it did the analysis of subgroups according to the dose of hCG used and the type of transfer, fresh or frozen, which is of great clinical relevance.
Regarding the time of intrauterine hCG application, the authors conclude that <15 minutes before transfer results in higher pregnancy rate than 6 hours and ≥48 hours. On this point, I have an issue.
Considering that:
• The mechanism of action of hCG described by authors cited in the review would be to alter the expression of cytokines related to implantation, as well as to lead to extracellular matrix rupture and loss of tight-junction [4, 5];
• embryo implantation occurs approximately on the seventh day after fertilization;
I think that as important as the time interval between intrauterine hCG injection and the embryo transfer is the stage of the embryo at transfer, if cleavage or blastocyst, since this will determine the time interval between the two major biologic events: hCG injection signaling and embryo implantation.
From this, I would like to know if subgroup analysis could contemplate this variable (embryo stage at transfer)?
Oscar Duarte-Filho, M.D.
References
[1] Gao M, Jiang X, Li B, Li L, Duan M, Zhang X, et al.: Intrauterine injection of human chorionic gonadotropin before embryo transfer can improve in vitro fertilization-embryo transfer outcomes: a meta-analysis of randomized controlled trials. Fertil Steril2019;112(1): 89-97.e81.
[2] Ye H, Hu J, He W, Zhang Y, Li C: The efficacy of intrauterine injection of human chorionic gonadotropin before embryo transfer in assisted reproductive cycles: Meta-analysis. J Int Med Res2015;43(6): 738-746.
[3] Osman A, Pundir J, Elsherbini M, Dave S, El-Toukhy T, Khalaf Y: The effect of intrauterine HCG injection on IVF outcome: a systematic review and meta-analysis. Reprod Biomed Online2016;33(3): 350-359.
[4] Tapia-Pizarro A, Argandoña F, Palomino WA, Devoto L: Human chorionic gonadotropin (hCG) modulation of TIMP1 secretion by human endometrial stromal cells facilitates extravillous trophoblast invasion in vitro. Hum Reprod2013;28(8): 2215-2227.
[5] Sacchi S, Sena P, Degli Esposti C, Lui J, La Marca A: Evidence for expression and functionality of FSH and LH/hCG receptors in human endometrium. J Assist Reprod Genet2018;35(9): 1703-1712.